Dialysis Interventions and Transplant Interventions
Gordon McLennan, MD (he/him/his)
CEO
Interventional Innovations Consulting, LLC
Disclosure(s): AKICept: Advisory Committee or Review Panel Member (Ongoing); Becton Dickenson: Advisory Committee or Review Panel Member (Ongoing); Trisalus: Ownership Interest (Ongoing)
Rishi Razdan, MD
Medical Director
Azura Vascular Care of Jacksonville
Disclosure(s): ABBOTT, ANGIODYNAMICS, ANGIOSAFE, BD BARD, BOSTON SCIENTIFIC, CSI – FRONTIER, INTACT VASCULAR, ABBOTT, MEDTRONIC, MICRO MEDICAL SOLUTIONS, PLURISTEM, LTD SURMODICS, VERYAN, VESPER MEDICAL: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)
Discuss updates in dialysis access and management
Speaker: Gordon McLennan, MD (he/him/his) – Interventional Innovations Consulting, LLC
Speaker: Bart Dolmatch, MD – PAMF and El Camino Hospital
Speaker: Bulent Arslan, MD, FSIR – Rush University Medical Center
Speaker: Clinton Nichols
Speaker: Gordon McLennan, MD (he/him/his) – Interventional Innovations Consulting, LLC
Speaker: Rishi N. Razdan, MD – Azura Vascular Care of Jacksonville